Investing.com -- 安进(Amgen)正式在印度海得拉巴启用其新的技术创新基地Amgen India。该公司承诺到2025年将在该基地投资2亿美元,并计划在未来几年继续追加投资。新基地将通过人工智能和数据科学增强安进的数字化能力,以推进其医药研发管线。这一举措同时也为当地人才创造了机会。
U.S. drugmaker Amgen will invest about $200 million this year in its new technology centre in southern India, with further ...
U.S. drugmaker Amgen will invest about $200 million this year in its new technology centre in southern India, with further ...
Amgen opens new technology and innovation site in Hyderabad, to invest $200 million through 2025: Our Bureau, Bengaluru ...
Hyderabad: US-based biopharma giant Amgen flagged off its first India investment with a new technology and innovation centre ...
The site is expected to accelerate Amgen’s digital capabilities through artificial intelligence and data science to further ...
Amgen has set up this new centre in Hyderabad to further technologically develop its range of medicines. It is developing the ...
Amgen (NASDAQ: AMGN) is investing $200 million in its new technology and innovation center in Hyderabad, India, to enhance AI ...
US - based drug maker Amgen has set up a new technology and innovation centre in Hyderabad and is planning to invest $200 ...
Amgen (AMGN) plans to invest about $200M this year in its new technology center in southern India, with further investments planned, Reuters’ ...
The facility, which occupies approximately 524,000 square feet across two towers in HITEC City, will focus on harnessing AI, ...
Amgen invests $200M in India's tech center to leverage AI for drug development. The U.S. FDA seeks to rehire 300 staff ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果